New N-methyl and N-ethyl substitutions in the indazole nucleus are reported by reacting 3-(2aminobenzamido)indazole and the appropriate trimethyl/triethyl orthobenzoate. Single crystal Xray analysis confirms the N-ethylation position for the 3-(1-ethyl-1H-indazol-3-yl)-2phenylquinazolin-4(3H)-one derivative 3f. Compounds 11a-d and 3a-d were tested to evaluate their antimicrobial, antiproliferative and COX Compound 9a was prepared by amidation of the N-(indazol-3-yl)-2-aminobenzamide 1a with benzoyl chloride 7 in pyridine. This reaction gave a mixture from which two products were isolated and identified as 8a and 9a (Scheme 3). By stirring 8a at room temperature in 20% alcoholic sodium hydroxide solution (24 h), the N-(indazol-3-yl)-2-benzamidobenzamide 9a was obtained Moreover, by maintaining the crude mixture at room temperature in 20% alcoholic sodium hydroxide solution (24 h), only the desired 9a was directly obtained in 50% yield.
Introduction
The 4(3H)-quinazolinone ring system I represents a very attractive scaffold to obtain new molecules endowed with a wide range of pharmacological properties.
It has been reported that the 4(3H)-quinazolinone moiety is present in a large number of compounds with anticonvulsant and CNS depressant, 1 analgesic and anti-inflammatory, 2 antitumoral, 3 antileukemic, 4 and antifungal 5 activities. As these pharmacological properties mostly depend on the substituents at 2 and 3 positions, we were interested since a long time to study the influence of different substituents on the 4(3H)-quinazolinone ring. Recently, the synthesis and the biological evaluation of some 2-phenyl-3-(substituted-benzothiazol-2-yl)-4(3H)-quinazolinone derivatives, endowed with anti-inflammatory and antimicrobial activities, have been reported. 6 In particular, the interesting antiproliferative activity of 3-indazolylsubstituted 4(3H)-quinazolinones bearing hydrogen, methyl or ethyl moieties at C(2) have drawn our attention. 7, 8 These observations prompted us to study in depth the 3-indazolyl-substituted 4(3H)-quinazolinones through the synthesis of new derivatives bearing a phenyl group at C (2) , in order to ascertain the role and the possible advantage of this substitution over the hydrogen, methyl or ethyl-analogs regarding the above mentioned biological activities.
Results and Discussion

Chemistry
The synthesis of the 3-indazolyl-substituted 4(3H)-quinazolinones 3a was first carried out by refluxing the 3-(2-aminobenzamido)indazole 1a in triethyl orthobenzoate 2f according to the previously described procedure (Scheme 1). 9
Scheme 1
Surprisingly, instead of the expected 3-(1H-indazol-3-yl)-2-phenylquinazolin-4(3H)-one 3a, a product having mass at M+28 was isolated. The analytical and the spectroscopic data of this product suggested an N-ethylation reaction of the indazole nucleus. In principle this reaction could give both the 3-(1-ethyl-1H-indazol-3-yl)-2-phenylquinazolin-4(3H)-one derivative 3f and the 3-(2-ethyl-2H-indazol-3-yl)-2-phenylquinazolin-4(3H)-one isomer 4. For a conclusive elucidation of the structure, an X-ray diffraction analysis was performed (see crystallography).
Furthermore, the reaction of compound 1a with trimethyl orthobenzoate 2g gave the Nmethylated indazole nucleus, probably the 3g derivative, as with the ethyl analogue.
A review of the literature showed that orthoesters are potential alkylating agents. 10 Our findings represent the first example of methylation/ethylation in the indazole series, evidencing that the methylation/ethylation of indazole nucleus is deeply influenced by the orthoester used in the reaction. In fact, the methylation/ethylation was observed only with the orthobenzoates, while the unethylated 3-indazolyl-4(3H)-quinazolinones were obtained if triethyl orthoformate, triethyl orthoacetate or triethyl orthopropionate were used. 8 The possible reason of such result was likely due to the higher boiling points of orthobenzoates with respect to the other orthoesters (Table 1) . In order to verify this statement, a mixture of 3-(2-aminobenzamido)indazole 1a in triethyl orthobenzoate 2f was left at 160°C for 5 hours (Scheme 1) giving the 3-(1H-indazol-3-yl)-2phenylquinazolin-4(3H)-one 3a as the main product (20% yield) together with the starting material, instead of the N-ethyl derivative 3f (Scheme 1).
For the synthesis of the novel 2-phenyl-3-(substituted-indazol-3-yl)-4(3H)-quinazolinones 3, we decided to evaluate two of the most frequently employed strategies: (i) via the benzoxazinone 6 as intermediate and ii) via the N-(indazol-3-yl)-2-benzamidobenzamide 9. The starting materials, 2-phenyl-3,1-benzoxazin-4-ones 6a-d [12] [13] [14] [15] were obtained with a novel procedure starting from the appropriate 2-aminobenzoic acid 5a-d and the triethyl orthobenzoate 2f by microwave assisted synthesis (Scheme 2). N-(Indazol-3-yl)-2-aminobenzamide 1a, 9 and 3aminoindazole 10, 11 were prepared according to the previously described method.
For that concerning the procedure having the benzoxazinone 6 as intermediate, the N-(2-(3amino-1H-indazole-1-carbonyl)phenyl)benzamides 11a-d were obtained via the fusion of the appropriate benzoxazinone 6a-d with 3-aminoindazole 10 at 160 °C for 15 minutes. Then the N-(2-(3-amino-1H-indazole-1-carbonyl)phenyl)benzamides 11a-d were heated at 260 °C for 15 minutes to give the desired 2-phenyl-3(indazol-3-yl)-quinazolin-4(3H)-ones 3a-d that were also obtained in one step by fusion of benzoxazinones 6a-d with 3-aminoindazole 10 at 260 °C for 15 minutes (Scheme 4).
Scheme 4
On the basis of the results of these two synthetic routes we can conclude that the cyclization of 11a-d into 3a-d occurred via thermal rearrangement of the benzoylamidobenzoyl group through the possible intermediate 9a-d (Scheme 5). A similar rearrangement was previously reported in the pyrazole series. 16 The molecular structure is characterized by the bicyclic quinazolinone moiety, substituted at C(8) with a phenyl ring, connected to an indazole substituted at N(4) by an ethyl group. The dihedral angle between the two bicyclic systems is 69.8(1)°, with the N(3)-C(15)-N(2)-C(1) torsion angle of -63.7(1)°. The benzene is inclined of 45.7(1)° and 60.1(1)° with respect to the quinazolinone and indazole systems respectively.
A comparison of the present structure with that of the 3-(indazol-3-yl)-methyl-quinazolin-4(3H)-one 9 shows as the insertion of the phenyl at C(8) causes a reduction of 16.7(1)° in the torsion angle N(3)-C(15)-N(2)-C (1) . The substitution of the hydrogen with the ethyl group modifies as expected the intermolecular interactions for that regarding the O(1), which weakly interacts with C(12) I -H at a distance of 2.52(1)Å, angle 151(1)° ( I at x+1, y+1, z). Additional contacts concern N(3)…C(5) II -H at 2.73(1)Å, angle 132(1)° ( II at 2-x, -y, -z). Molecular stacking is also present between the quinazolinone moieties centrosymmetrically related ( Figure 2 ).
Biology
Compounds 3a-d and 11a-d were preliminary tested to evaluate their antimicrobial effects against E. coli, P. aeruginosa, S. aureus, E. fecalis and C. albicans as well as their antiproliferative activity against K-562 (human chronic myelogenus leukemia), HT29 (colon cancer cells) and NCI-H460 (human large cell lung cancer cells). The analysis of the biological data shows no antimicrobial activity at 50 µM concentration in all the synthesized compounds. Results of the antiproliferative activity exhibit scarcely or moderately activity ranging from 10.0-20.0 % (10 µM) against K562, 12.9-52.3 % (100 µM) against HT29, and 13.1-41.7 % (100 µM) against NCIH460 cell lines. Compounds 3a-d and 11a-d were also tested as COX1/COX2 inhibitors ( Table 2) . Data reported in Table 2 show that compound 3 and 11 are endowed of inhibitory activity against COX-1 and COX-2. In particular, the N-(2-(3-amino-1H-indazole-1carbonyl)phenyl)benzamides 3a, 11b-d seem to be lightly selective towards the COX-1 isoform, while the 3-(indazol-3-yl)-quinazolin-4(3H)-one derivatives 3b-d 11a possess a moderate COX-2 selectivity.
Conclusions
Reactions of 3-(2-aminobenzamido)indazole and the appropriate trimethyl/triethyl orthobenzoate give N-methyl/N-ethylation of the indazole nucleus, representing the first example of Nalkylation in the indazole series. This is probably related to the higher boiling point of the orthobenzoate than the other orthoesters, for which the N-alkylation does not occur. The correct position of the N-alkylation has been clarified by the X-ray analysis of the 3-
11a-d present scarcely or moderately antiproliferative activity against K-562 (human chronic myelogenus leukemia), HT29 (colon cancer cells) and NCI-H460 (human large cell lung cancer cells). In vitro testing for 3 and 11 indicated that they are endowed with inhibitory activity against COX-1 and COX-2. Further investigation of biology of this kind of products is in progress and the results were published elsewhere.
Experimental Section
General. All melting points were determined on a Buchi 530 capillary melting points apparatus; IR spectra were recorded with a Jasco Spectrum IR-810. System spectrophometer as solid in KBr disc or nujol mull supported on NaCl disks; 1 H and 13 C NMR spectra were obtained in DMSO-d 6 at 300.13 and 75.47 MHz respectively, using a Bruker AC series 300 MHz spectrometer (TMS as internal reference). Mass spectra were recorded on a JEOL jms-0I-SG-2 spectrometer at 75 eV (100µA). Microanalyses (C, (8 ml), benzoyl chloride 7 (10 mmoles) was added dropwise. Stirring was continued for 24 h then the solution was concentrated to dryness under reduced pressure. The residue was left under magnetic stirrer for 24 h with 20% potassium hydroxide aqueous solution, the solid that separated out was filtered off and recrystallized from ethanol to give pure 9a which was identical to that synthesized by method A (Rf, mp, mixed mp, IR, 1 HNMR); yields 50%. [12] [13] [14] [15] 10 mmol of the appropriate 2-aminobenzoic acid 5a-d were added of 4.5 ml of triethyl orthobenzoate. The microwave assisted reactions were run for 7 min at 385 W for the first 5 min then at 490 W for the last 2 min. The crude white product was filtered and crystallized from ethyl acetate to give pure 6a-d; yields 51-90%.
General procedure for 2-phenyl-3,1-benzoxazin-4-ones (6a-d)
General procedure for N-(2-(3-amino-1H-indazole-1-carbonyl)phenyl)benzamides (11a-d)
Equimolar amounts of the appropriate 2-phenyl-benzoxazin-4-one 6a-d and 3-aminoindazole 10 9 were heated at 160° C for 15 minutes. After this time, the solid obtained was crystallized from ethanol to give pure 11a-d. 11a. Yield 37%; mp 167°C (ethanol); IR (KBr) cm -1 3456-3213 (NH, NH 2 ), 1672 (CO); 1 H-NMR (δ) DMSO-d 6 
General procedure for 2-phenyl-3(indazol-3-yl)-quinazolin-4(3H)-ones (3a-d) Method
A. which was identical to that synthesized by methods A and B (Rf, mp, mixed mp, IR, 1 HNMR); yields 3a 40%.
General procedure for 3-(1-alkyl-1H-indazol-3-yl)-2-phenylquinazolin-4(3H)-ones (3f,g)
4 Mmoles of 3-(2-aminobenzamido)indazole 1 were dissolved by heating in 10 ml of orthobenzoate 2f,g and the solution was refluxed for 10 h. Evaporation of the solvent under reduced pressure gave a residue which was recrystallized from ethanol to give pure 3g,f. 3f. Yield 55-65 %; mp 208-210°C; MS (m/z) 366 (M + ); IR (KBr) cm -1 1685 (CO); 1 H-NMR(δ) DMSO-d 6 1.01(2H, t, CH2), 4.28-4.33 (3H, broad, CH 3 ), 7.12-7.67 (13H, a set of signals, C 6 H 5 and 2xC 6 H 4 ); 13 C-NMR(δ) DMSO-d 6 Crystals of 3f were obtained as colorless prisms from a water-methanol 1:1 solution by slow evaporation at room temperature. They were mounted on an Enraf Nonius CAD-4 diffractometer using MoKα (λ MoKα =0.71073Å) radiation at room temperature (293K). The lattice parameters were determined by least-squares refinements of 25 high angle reflections. The structure was solved by direct methods, 19 and the refinement was carried out by full-matrix least-squares with SHELX-97. 20 All non-H-atoms were refined anisotropically. A summary of the crystal data, data collection, and structure refinement is presented in Table 3 ; selected bond lengths and angles are reported in Table 4 . Geometrical calculations were carried out with the program PARST. 21 
Biology
The antimicrobial effects against E. coli ATCC 25922, P. aeruginosa ATCC 27853, S. aureus ATCC 29213, E. faecalis ATCC 29212, and Candida albicans ATCC 10213 as well as the antiproliferative activity against NCI-H460 (human non-small-lung cancer), HT-29 (COX2 +/+ , p53 -/-)(human colon adenocarcinoma), HCT116 (COX2 -/-, p53 +/+ ) (human colon cancer) and MCF-7 (breast cancer) cell lines were performed by general methods previously described. 22, 23 The ability of the test compound to inhibit the conversion of arachidonic acid to prostaglandin H 2 (PGH 2 ) was determined using a COX1/COX2 inhibitor screening assay kit (cat. n#560101;Cayman Chemical, Ann Arbor, MI).
